vs
Bloom Energy Corp（BE）与德康医疗（DXCM）财务数据对比。点击上方公司名可切换其他公司
德康医疗的季度营收约是Bloom Energy Corp的1.7倍（$1.3B vs $751.1M），德康医疗净利率更高（21.2% vs 9.4%，领先11.8%），德康医疗同比增速更快（21.6% vs -3.4%），过去两年Bloom Energy Corp的营收复合增速更高（51.7% vs 12.0%）
Bloom Energy Corp是一家能源技术企业，由印裔美国工程师、发明家、企业家KR·斯里达尔创立，他同时担任公司董事长兼首席执行官。斯里达尔此前曾任亚利桑那大学航空航天与机械工程教授、空间技术实验室主任，曾为NASA提供顾问服务，现为美国国家工程院院士。
德康医疗是美国跨国医疗保健企业，专注于研发、生产及销售糖尿病管理领域的连续血糖监测（CGM）系列系统。其全球总部及研发中心位于美国加利福尼亚州圣地亚哥，生产基地分布于美国亚利桑那州梅萨、马来西亚峇都交湾及爱尔兰戈尔韦郡阿斯里。
BE vs DXCM — 直观对比
营收规模更大
DXCM
是对方的1.7倍
$751.1M
营收增速更快
DXCM
高出25.0%
-3.4%
净利率更高
DXCM
高出11.8%
9.4%
两年增速更快
BE
近两年复合增速
12.0%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $751.1M | $1.3B |
| 净利润 | $70.7M | $267.3M |
| 毛利率 | 30.0% | 62.9% |
| 营业利润率 | 17.3% | 25.6% |
| 净利率 | 9.4% | 21.2% |
| 营收同比 | -3.4% | 21.6% |
| 净利润同比 | 396.7% | 153.6% |
| 每股收益（稀释后） | $0.44 | $0.67 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BEDXCM
| Q1 26 | $751.1M | $1.3B | ||
| Q4 25 | $772.8M | $1.3B | ||
| Q3 25 | $513.3M | $1.2B | ||
| Q2 25 | $396.3M | $1.2B | ||
| Q1 25 | $319.3M | $1.0B | ||
| Q4 24 | $567.0M | $1.1B | ||
| Q3 24 | $321.8M | $994.2M | ||
| Q2 24 | $326.5M | $1.0B |
净利润BEDXCM
| Q1 26 | $70.7M | $267.3M | ||
| Q4 25 | $1.4M | $267.3M | ||
| Q3 25 | $-23.0M | $283.8M | ||
| Q2 25 | $-42.2M | $179.8M | ||
| Q1 25 | $-23.4M | $105.4M | ||
| Q4 24 | $105.2M | $151.7M | ||
| Q3 24 | $-14.6M | $134.6M | ||
| Q2 24 | $-61.2M | $143.5M |
毛利率BEDXCM
| Q1 26 | 30.0% | 62.9% | ||
| Q4 25 | 31.0% | 62.9% | ||
| Q3 25 | 29.5% | 60.5% | ||
| Q2 25 | 27.0% | 59.5% | ||
| Q1 25 | 27.8% | 56.9% | ||
| Q4 24 | 38.7% | 58.9% | ||
| Q3 24 | 24.5% | 59.7% | ||
| Q2 24 | 21.0% | 62.4% |
营业利润率BEDXCM
| Q1 26 | 17.3% | 25.6% | ||
| Q4 25 | 11.3% | 25.6% | ||
| Q3 25 | 1.5% | 20.1% | ||
| Q2 25 | -0.9% | 18.4% | ||
| Q1 25 | -6.0% | 12.9% | ||
| Q4 24 | 18.5% | 17.0% | ||
| Q3 24 | -3.0% | 15.3% | ||
| Q2 24 | -7.1% | 15.7% |
净利率BEDXCM
| Q1 26 | 9.4% | 21.2% | ||
| Q4 25 | 0.2% | 21.2% | ||
| Q3 25 | -4.5% | 23.5% | ||
| Q2 25 | -10.6% | 15.5% | ||
| Q1 25 | -7.3% | 10.2% | ||
| Q4 24 | 18.5% | 13.6% | ||
| Q3 24 | -4.5% | 13.5% | ||
| Q2 24 | -18.7% | 14.3% |
每股收益（稀释后）BEDXCM
| Q1 26 | $0.44 | $0.67 | ||
| Q4 25 | $99.91 | $0.67 | ||
| Q3 25 | $-100.00 | $0.70 | ||
| Q2 25 | $-0.18 | $0.45 | ||
| Q1 25 | $-0.10 | $0.27 | ||
| Q4 24 | $0.45 | $0.37 | ||
| Q3 24 | $-0.06 | $0.34 | ||
| Q2 24 | $-0.27 | $0.35 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $917.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $948.0K | $2.7B |
| 总资产 | $4.7B | $6.3B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BEDXCM
| Q1 26 | — | $917.7M | ||
| Q4 25 | $2.5B | $917.7M | ||
| Q3 25 | $595.1M | $1.8B | ||
| Q2 25 | $574.8M | $1.2B | ||
| Q1 25 | $794.8M | $904.9M | ||
| Q4 24 | $802.9M | $606.1M | ||
| Q3 24 | $495.7M | $621.2M | ||
| Q2 24 | $581.7M | $939.2M |
总债务BEDXCM
| Q1 26 | — | — | ||
| Q4 25 | $2.6B | — | ||
| Q3 25 | $1.1B | — | ||
| Q2 25 | $1.1B | — | ||
| Q1 25 | $1.1B | — | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $1.1B | — | ||
| Q2 24 | $1.1B | — |
股东权益BEDXCM
| Q1 26 | $948.0K | $2.7B | ||
| Q4 25 | $768.6M | $2.7B | ||
| Q3 25 | $653.1M | $2.7B | ||
| Q2 25 | $594.6M | $2.6B | ||
| Q1 25 | $578.3M | $2.3B | ||
| Q4 24 | $562.5M | $2.1B | ||
| Q3 24 | $430.9M | $2.0B | ||
| Q2 24 | $423.3M | $2.4B |
总资产BEDXCM
| Q1 26 | $4.7B | $6.3B | ||
| Q4 25 | $4.4B | $6.3B | ||
| Q3 25 | $2.6B | $7.5B | ||
| Q2 25 | $2.5B | $7.3B | ||
| Q1 25 | $2.6B | $6.8B | ||
| Q4 24 | $2.7B | $6.5B | ||
| Q3 24 | $2.6B | $6.4B | ||
| Q2 24 | $2.5B | $6.8B |
负债/权益比BEDXCM
| Q1 26 | — | — | ||
| Q4 25 | 3.41× | — | ||
| Q3 25 | 1.73× | — | ||
| Q2 25 | 1.91× | — | ||
| Q1 25 | 1.96× | — | ||
| Q4 24 | 2.01× | — | ||
| Q3 24 | 2.62× | — | ||
| Q2 24 | 2.66× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BE
| Product | $653.3M | 87% |
| Service | $61.9M | 8% |
| Installation | $25.9M | 3% |
| Electricity | $9.9M | 1% |
DXCM
暂无分部数据
